Type 1 Diabetes Market Outlook: Emerging Therapies Reshape Future Opportunities DelveInsight’s latest Type 1 Diabetes Market Report highlights strong growth potential through 2034, led by disease-modifying breakthroughs like TZIELD and advances in stem-cell and weekly insulin therapies. The US dominates with 89% market share, followed by the EU4, UK, and Japan. Leading innovators include...